Portable Diagnostic Systems Inc.
Robbinsville Township, NJ
- UEI
- F3PMSK7KM3K8
- CAGE
- 8DEQ2
- Primary NAICS
- 334516 Analytical Laboratory Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 103 Ely Crescent, Robbinsville Twp, NJ 08691, USA
- Website
- portabledx.com
- Founded
- 2019
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $2,000,000 |
| FY2024 | $0 |
| FY2023 | $400,000 |
Contract awards
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| PA22176, sbir, phase I, microfluidic immunoassay as a polysubstance oral fluid screening tool for law enforcement to… | Office of Financial Resources (CDC) | $551,532 |
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Emory University | U54EB027690 | $50,000 |
Similar vendors
About the company
Portable Diagnostic Systems Inc. is a veteran-owned, for-profit corporate entity registered in the System for Award Management (SAM) from August 2019 to January 2026, located in Robbinsville Township, New Jersey. The company specializes in developing advanced diagnostic and biosensing technologies, with a primary focus on creating innovative microfluidic and lab-on-a-chip systems for toxicology and drug detection applications. Their technological solutions appear targeted at addressing critical public health and safety challenges, particularly in the areas of postmortem toxicology and roadside drug screening.
Through federal contract awards, Portable Diagnostic Systems Inc. has been awarded two significant Small Business Innovation Research (SBIR) contracts from the National Institute on Drug Abuse (NIDA). The first contract, a Phase I award valued at $400,000 with a performance period from September 2023 to September 2024, and the second, a Phase II contract valued at $2,000,000 spanning September 2025 to August 2027, both focus on developing an ultraportable lab-on-a-chip biosensor system for rapid postmortem toxicology. These contracts are set aside for small businesses and represent the company's expertise in developing advanced diagnostic technologies for forensic and medical applications. The definitive contracts demonstrate the company's capability to develop sophisticated, portable diagnostic tools that can potentially revolutionize toxicology screening processes.
In terms of federal grant awards, Portable Diagnostic Systems Inc. has received a cooperative agreement grant from the Office of the Director, awarded on September 30, 2023, with a completion date of February 28, 2025. This grant, designated as PA22176, supports the development of a microfluidic immunoassay as a polysubstance oral fluid screening tool for law enforcement. The grant aims to create a rapid drug detection method to help reduce traffic fatalities and injuries by enabling quick identification of recent drug use during traffic stops. This grant award further underscores the company's commitment to developing innovative diagnostic technologies that can have significant public safety implications, particularly in the realm of drug detection and traffic safety.
Quick answers
Is Portable Diagnostic Systems Inc. registered in SAM.gov?
Yes. Portable Diagnostic Systems Inc.'s SAM.gov registration is active through January 20, 2027.
What is Portable Diagnostic Systems Inc.'s CAGE code?
Portable Diagnostic Systems Inc.'s CAGE code is 8DEQ2, and its Unique Entity ID (UEI) is F3PMSK7KM3K8.
How much has Portable Diagnostic Systems Inc. received in federal contracts?
Federal contracts obligated $2,000,000 to Portable Diagnostic Systems Inc. in fiscal year 2025 and $2,400,000 in fiscal years 2023 through 2027.
How does Portable Diagnostic Systems Inc. rank among federal contractors?
Portable Diagnostic Systems Inc. ranked #46 in PSC AN11 in FY2025.
What is Portable Diagnostic Systems Inc.'s most recent federal award?
Portable Diagnostic Systems Inc.'s most recent federal contract award is FY25. Sbir topic 167 phase II: ultraportable lab-on-a-chip biosensor system for rapid postmortem toxicology. Period… (75N95025C00008), from National Institute on Drug Abuse (NIH), on September 1, 2025.
On GovTribe
See Portable Diagnostic Systems Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors